Alison J. Clare
Bristol, ENG BS81TD, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Can NRF2 provide a gene-agnostic approach to treating age-related macular degeneration?
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 13, 2026
Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 09, 2025
Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy.
Journal: Progress in retinal and eye research
Published: December 01, 2024
Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration.
Journal: Science translational medicine
Published: June 05, 2024
Characterization of the ocular inflammatory response to AAV reveals divergence by sex and age.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 09, 2024
Replenishing Age-Related Decline of IRAK-M Expression in Retinal Pigment Epithelium Attenuates Outer Retinal Degeneration.
Journal: bioRxiv : the preprint server for biology
Published: October 09, 2023
Unravelling the therapeutic potential of IL-33 for atrophic AMD.
Journal: Eye (London, England)
Published: June 04, 2021
Treatment with interleukin-33 is non-toxic and protects retinal pigment epithelium in an ageing model of outer retinal degeneration.
Journal: Journal of cellular and molecular medicine
Published: August 14, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026